Galmed Pharmaceuticals (GLMD) Shares Outstanding (Weighted Average) (2013 - 2025)

Galmed Pharmaceuticals' Shares Outstanding (Weighted Average) history runs 13 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 363.17% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $4.3 million (up 363.17% YoY), while the FY2025 annual figure was $4.3 million, up 2387.31% from the prior year.
• Shares Outstanding (Weighted Average) was $4.3 million for Q4 2025 at Galmed Pharmaceuticals, up from $1470.0 in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $4.3 million in Q4 2025 to a low of $620.0 in Q1 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $384284.2 across 5 years, with a median of $4785.0 in 2022.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Weighted Average) surged 130934.48% in 2021, then tumbled 99.03% in 2022.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.6 million in 2021, then plunged by 91.48% to $139682.0 in 2022, then soared by 65.23% to $230795.0 in 2023, then jumped by 303.31% to $930822.0 in 2024, then soared by 363.17% to $4.3 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $4.3 million (Q4 2025), $1470.0 (Q3 2025), and $1250.0 (Q2 2025), per Business Quant data.